Bambusa Therapeutics at a glance
As of- [1] Total funding (reported): PR Newswire, October 29, 2026
Is this your company? Get featured or correct your listing →
Recent changes
- Oct 30, 2026Oct 30, 2026Bambusa Therapeutics Prices $168.9M IPO, Debuts As BBTX Pulse story
- Oct 29, 2026Oct 29, 2026IPO $168.9M PR Newswire
- Oct 29, 2026Oct 29, 2026First reported total funding: $136.1M (pre-IPO) PR Newswire
Debt, IPO & other events
not counted in equity raised| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2026 | ipo | $168.9M | — | RA CapitalLeadunverified | PR Newswire |
Investors
Latest Pulse
- Oct 30, 2026OPay Leads $613.5M Week Of Priced IPOsThree IPOs priced between Oct. 27-30, 2026 raised a combined $613.5 million, led by OPay's $304 million NYSE debut, while biotechs Bambusa Therapeutics and Aspen Neuroscience priced the same morning.→
- Oct 30, 2026Two Biotechs Price IPOs The Same Day: BBTX And ASPEBambusa Therapeutics and Aspen Neuroscience both priced IPOs on October 29, 2026, debuting on Nasdaq the same morning as BBTX and ASPE, in what BioSpace calls a cautiously optimistic biotech IPO rebound.→
- Oct 30, 2026Bambusa Therapeutics Prices $168.9M IPO, Debuts As BBTXBambusa Therapeutics priced an upsized IPO of 10,555,555 shares at $16.00, raising $168.9 million, with shares set to begin trading on Nasdaq as BBTX on October 30, 2026.→
Coverage Timeline
newest firstAll Coverage
IPO$613.5M Combined (3 IPOs)
OPay Leads $613.5M Week Of Priced IPOs
Three IPOs priced between Oct. 27-30, 2026 raised a combined $613.5 million, led by OPay's $304 million NYSE debut, while biotechs Bambusa Therapeutics and Aspen Neuroscience priced the same morning.
BY THE NUMBERS
Two Biotechs Price IPOs The Same Day: BBTX And ASPE
IPO2 IPOs, Same Day
Two Biotechs Price IPOs The Same Day: BBTX And ASPE
Bambusa Therapeutics and Aspen Neuroscience both priced IPOs on October 29, 2026, debuting on Nasdaq the same morning as BBTX and ASPE, in what BioSpace calls a cautiously optimistic biotech IPO rebound.
BY THE NUMBERS
Bambusa Therapeutics Prices $168.9M IPO, Debuts As BBTX
IPO$168.9M IPO
Bambusa Therapeutics Prices $168.9M IPO, Debuts As BBTX
Bambusa Therapeutics priced an upsized IPO of 10,555,555 shares at $16.00, raising $168.9 million, with shares set to begin trading on Nasdaq as BBTX on October 30, 2026.
DEEP DIVE
Value Add Research
Related Companies
Bambusa Therapeutics FAQ
How much has Bambusa Therapeutics raised?
Bambusa Therapeutics has raised $136.1M (pre-IPO) in total funding, according to PR Newswire (October 29, 2026).
Sources & methodologyshow
Where these figures come from
- PR Newswireprimary source2 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.